Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

465 ARTÍCULOS , VIENDO DEL 76 AL 90

The role of amyloid β in the pathogenesis of Alzheimer's disease

Gilbert BJ.

J Clin Pathol. 2013 May;66(5):362-6. doi: 10.1136/jclinpath-2013-201515. Epub 2013 Mar 23.

The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease

Crimins JL, Pooler A, Polydoro M, Luebke JI, Spires-Jones TL.

Ageing Res Rev. 2013 Jun;12(3):757-63. doi: 10.1016/j.arr.2013.03.002. Epub 2013 Mar 22.

A canine model of human aging and Alzheimer's disease

Head E.

Biochim Biophys Acta. 2013 Sep;1832(9):1384-9. doi: 10.1016/j.bbadis.2013.03.016. Epub 2013 Mar 23.

Metabolic basis of sporadic Alzeimer's disease. role of hormones related to energy metabolism

Folch J, Pedrós I, Patraca I, Martínez N, Sureda F, Camins A.

Curr Pharm Des. 2013;19(38):6739-48. doi: 10.2174/13816128113199990612.

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease

Araki W.

BMC Med. 2013 Mar 26;11:82. doi: 10.1186/1741-7015-11-82.

Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review

Raudino F.

Neurol Sci. 2013 Aug;34(8):1275-82. doi: 10.1007/s10072-013-1424-7. Epub 2013 Mar 31.

The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD

Hunter S, Arendt T, Brayne C.

Mol Neurobiol. 2013 Dec;48(3):556-70. doi: 10.1007/s12035-013-8445-3. Epub 2013 Apr 3.

Alzheimer's disease and granulocyte density diversity

Järemo P, Milovanovic M, Buller C, Nilsson S, Winblad B.

Eur J Clin Invest. 2013 Jun;43(6):545-8. doi: 10.1111/eci.12072. Epub 2013 Mar 29.

Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review

Serý O, Povová J, Míšek I, Pešák L, Janout V.

Folia Neuropathol. 2013;51(1):1-9. doi: 10.5114/fn.2013.34190.

New genes and new insights from old genes: update on Alzheimer disease

Ringman JM, Coppola G.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):358-71. doi: 10.1212/01.CON.0000429179.21977.a1.

Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)

Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group.

Alzheimers Dement. 2013 Nov;9(6):714-23. doi: 10.1016/j.jalz.2012.11.012. Epub 2013 Apr 3.

SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians

Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M, Tomita N, Arai H, Asada T, Harigaya Y, Ikeda M, Amari M, Hanyu H, Higuchi S, Ikeuchi T, Nishizawa M, Suga M, Kawase Y, Akatsu H, Kosaka K, Yamamoto T, Imagawa M, Hamaguchi T, Yamada M, Morihara T, Takeda M, Takao T, Nakata K, Fujisawa Y, Sasaki K, Watanabe K, Nakashima K, Urakami K, Ooya T, Takahashi M, Yuzuriha T, Serikawa K, Yoshimoto S, Nakagawa R, Kim JW, Ki CS, Won HH, Na DL, Seo SW, Mook-Jung I; Alzheimer Disease Genetics Consortium; St George-Hyslop P, Mayeux R, Haines JL, Pericak-Vance MA, Yoshida M, Nishida N, Tokunaga K, Yamamoto K, Tsuji S, Kanazawa I, Ihara Y, Schellenberg GD, Farrer LA, Kuwano R.

PLoS One. 2013;8(4):e58618. doi: 10.1371/journal.pone.0058618. Epub 2013 Apr 2.

Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease

Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM.

Am J Geriatr Psychiatry. 2013 Jun;21(6):509-19. doi: 10.1016/j.jagp.2012.10.022. Epub 2013 Mar 13.

Discordance in the anatomical locations between morphological and perfusion changes occurring with the progression of Alzheimer's disease

Ogomori K, Majima S, Kuwabara Y, Takano K, Nonokuma M, Yoshimitsu K, Nishimura R.

Ann Nucl Med. 2013 May;27(4):371-7. doi: 10.1007/s12149-013-0709-5. Epub 2013 Apr 10.

Innate immunity in Alzheimer's disease: a complex affair

Guillot-Sestier MV, Town T.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):593-607. doi: 10.2174/1871527311312050008.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias